Cancer Research · 2019 · 40 citations · 40 references
MedicineCancer BiologyOncologyApoptosisMolecular OncologyTranscriptional RegulationCancer Cell SignalingEpigenetic Regulation In CancerMalignant NeoplasmsOncogenic Signaling PathwaysPromoter RegulationTumor Suppressor GenesCancer Signaling PathwaysEpigenetic Silencing Of Tumor Suppressor GenesMtorc1 SignalingOncogenic TransformationTranscriptional RepressionTranscriptional Repression MechanismsTranscriptional Repressor ComplexesTumor Suppression Mechanisms
Abstract Epigenetic silencing of promoter and enhancer regions is a common phenomenon in malignant cells. The transcription factor STAT3 is aberrantly activated in several tumors, where its constitutive acetylation accounts for the transcriptional repression of a number of tumor suppressor genes (TSG) via molecular mechanisms that remain to be understood. Using nucleophosmin-anaplastic lymphoma kinase–positive (NPM-ALK+) anaplastic large-cell lymphoma (ALCL) as model system, we found in cells and patient-derived tumor xenografts that STAT3 is constitutively acetylated as a result of ALK activity. STAT3 acetylation relied on intact ALK-induced PI3K- and mTORC1-dependent signaling and was sensitive to resveratrol. Resveratrol lowered STAT3 acetylation, rescued TSG expression, and induced ALCL apoptotic cell death. STAT3 constitutively bound the Sin3A transcriptional repressor complex, and both STAT3 and Sin3A bound the promoter region of silenced TSG via a resveratrol-sensitive mechanism. Silencing SIN3A caused reexpression of TSG, induced ALCL apoptotic cell death in vitro, and hindered ALCL tumorigenic potential in vivo. A constitutive STAT3–Sin3A interaction was also found in breast adenocarcinoma cells and proved critical for TSG silencing and cell survival. Collectively, these results suggest that oncogene-driven STAT3 acetylation and its constitutive association with Sin3A represent novel and concomitant events contributing to STAT3 oncogenic potential. Significance: This study delineates the transcriptional regulatory complex Sin3A as a mediator of STAT3 transcriptional repressor activity and identifies the STAT3/Sin3A axis as a druggable target to antagonize STAT3-addicted tumors.
40
Stat3 Dimerization Regulated by Reversible Acetylation of a Single Lysine Residue
Zhenglong Yuan, Yingjie Guan, Devasis Chatterjee et al. · Science · 2005 · 777 citations